Masters Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-500,000
Closed -$50.1M 97
2025
Q3
$50.1M Buy
+500,000
New +$45M 1.82% 14
2024
Q4
Sell
-500,000
Closed -$49.4M 87
2024
Q3
$49.4M Buy
+500,000
New +$49.1M 2.41% 8
2023
Q4
Sell
-500,000
Closed -$36.5M 78
2023
Q3
$36.5M Buy
+500,000
New +$39.9M 2.03% 15
2022
Q3
Sell
-3,000,000
Closed -$223M 58
2022
Q2
$223M Buy
3,000,000
+2,000,000
+200% +$150M 10.42% 3
2022
Q1
$89.9M Buy
+1,000,000
New +$92.3M 3.62% 7
2020
Q2
Sell
-1,500,000
Closed -$116M 65
2020
Q1
$116M Buy
+1,500,000
New +$133M 13.49% 2
2016
Q2
Sell
-1,000,000
Closed -$51.7M 80
2016
Q1
$51.7M Buy
+1,000,000
New +$51.9M 1.08% 20

Other funds holding XBI